Epilepsy Canada

10/10/2026

October 10 is . 🧠

People living with epilepsy may experience higher rates of depression and anxiety.

Drop a 💜 below to show your support for those living with epilepsy.

10/09/2026

Meet the Palm family!

This month, they are participating in the 1IN100 Challenge to raise awareness and funds for crucial epilepsy research.

Dravet syndrome is a rare, severe, lifelong developmental and epileptic encephalopathy that usually begins in the first year of life in previously healthy infants.

Epilepsy Canada has funded Dravet syndrome research, led by Dr. Andrade at the Krembil Brain Institute, University of Toronto. Learn more: https://heyor.ca/0F2IPo

Donate to the 1IN100 Challenge:
https://heyor.ca/VUjWmQ

10/08/2026

Last week, the Epilepsy Canada team attended the Canadian Epilepsy Research Initiative (CERI) symposium, hosted by Canadian League Against Epilepsy at the White Oaks Resort, in Niagara-on-the-lake, Ontario.

The conference was a fantastic opportunity to learn more about the important epilepsy and neurology research that takes place across the country, connect with industry folks and spread awareness about Epilepsy Canada's available research grants.

We will be highlighting research over the coming months, stay tuned! 🧠💜

Seen here: (1) Our team! (2) A quick interview with Dr. Morris Scantlebury, Pediatric Neurologist, Epileptologist, Scientist at University of Calgary AND Chair of our Scientific Research Committee (3) Our CEO Johanna McDougall welcoming everyone (4) some of the amazing research being done.

10/06/2026

Epilepsy is complex, and it looks different for everyone. 💜

For Dillon, living with epilepsy means his life has been shaped by seizures, medication and surgery. 🧠

Research helps us understand epilepsy, and improve treatment options for people living with epilepsy.

Help us fund the next scientific discovery:
➡️epilepsy.ca/donateonline

09/30/2026

Tomorrow, we move! 💜🏃‍♂️🚴‍♂️

The 1IN100 Challenge kicks off tomorrow, October 1!

Move 100km in support for epilepsy research and people living with epilepsy.

You can join Strava for free to track your progress, and join our community, and stay motivated. 🏃‍♂️🚴‍♂️🏊

It's not too late to register for the 1IN100 Challenge:
epilepsy.ca/1in100-challenge

09/30/2026

The National Day for Truth and Reconciliation is observed annually on September 30th in Canada to honour residential school Survivors, remember the children who never returned home, and recognize the enduring impacts of the residential school system.

09/29/2026

The 1IN100 Challenge officially starts in less than 2️⃣ days! 📆🏃‍♂️🚴‍♂️

The challenge: move 100km in the month of October in support of epilepsy research.

The why: 1 in 100 Canadians live with epilepsy, and for them, the challenges are everyday.

It's not too late to join us!

Register today:
➡️ epilepsy.ca/1in100-challenge

09/28/2026

In a crowd of 100 people, one of them may have epilepsy.

Yet, many questions remain about this complex condition.

Scientific discovery starts with donors like you.

Fund the research. ⬇️💜
epilepsy.ca/donateonline

09/26/2026

Epilepsy research outcomes have a real impact on people living with epilepsy and their families. 💜

For Venessa, participating in the 1IN100 Challenge is a way to fundraise for better treatment options while honouring her late sister, Athena. 💜

What's your why? Join us this October. 💜
Learn more and register today:
epilepsy.ca/1in100-challenge

09/25/2026

Please join us in congratulating Dr. Peter Carlen, recipient of the Robert Conlon Research Grant! 💜

Dr. Carlen and his team at University Health Network research aims to develop a safe, cost-effective, non-toxic treatment that combines multiple antioxidants for people with drug-resistant epilepsy, which is about one-third of people living with epilepsy. This approach could help reduce seizures and improve epilepsy-related coexisting conditions.

Learn more about Dr. Carlen’s research and Bob Conlon, whose name this grant honours: epilepsy.ca/grants-awarded/robertconlonawardpetercarlen

This is the first of three research grants Epilepsy Canada will announce this fall, representing $700,000 in research funding. We’re excited to share more of the work this support will make possible.

Research in Action is brought to you by Jazz Pharmaceuticals

Dr. Peter Carlen, MD, FRCPC Neurologist, Toronto Western Hospital Professor, University of Toronto Senior Scientist, University Health Network Grant Project: Mitochondrial Medicine for Epilepsy: a formulation of multiple antioxidants to treat epilepsy and comorbidities.